SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-24-086334
Filing Date
2024-08-06
Accepted
2024-08-06 17:01:05
Documents
5
Effectiveness Date
2024-08-06

Document Format Files

Seq Description Document Type Size
1 S-8 tm2420634d3_s8.htm S-8 55124
2 EXHIBIT 5.1 tm2420634d3_ex5-1.htm EX-5.1 13032
3 EXHIBIT 23.1 tm2420634d3_ex23-1.htm EX-23.1 2210
4 EX-FILING FEES tm2420634d3_ex-filingfees.htm EX-FILING FEES 13258
5 GRAPHIC tm2420634d3_ex5-1img001.jpg GRAPHIC 2514
  Complete submission text file 0001104659-24-086334.txt   88314
Mailing Address 611 GATEWAY BOULEVARD, SUITE 900 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BOULEVARD, SUITE 900 SOUTH SAN FRANCISCO CA 94080 650-624-1100
RIGEL PHARMACEUTICALS INC (Filer) CIK: 0001034842 (see all company filings)

IRS No.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-281306 | Film No.: 241180291
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)